These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132 [TBL] [Abstract][Full Text] [Related]
6. CDH1 pathogenic variants and cancer risk in an unselected patient population. Bar-Mashiah A; Soper ER; Cullina S; Belbin GM; Kenny EE; Lucas AL; Abul-Husn NS Fam Cancer; 2022 Apr; 21(2):235-239. PubMed ID: 33886068 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394 [TBL] [Abstract][Full Text] [Related]
8. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. van der Post RS; Vogelaar IP; Carneiro F; Guilford P; Huntsman D; Hoogerbrugge N; Caldas C; Schreiber KE; Hardwick RH; Ausems MG; Bardram L; Benusiglio PR; Bisseling TM; Blair V; Bleiker E; Boussioutas A; Cats A; Coit D; DeGregorio L; Figueiredo J; Ford JM; Heijkoop E; Hermens R; Humar B; Kaurah P; Keller G; Lai J; Ligtenberg MJ; O'Donovan M; Oliveira C; Pinheiro H; Ragunath K; Rasenberg E; Richardson S; Roviello F; Schackert H; Seruca R; Taylor A; Ter Huurne A; Tischkowitz M; Joe ST; van Dijck B; van Grieken NC; van Hillegersberg R; van Sandick JW; Vehof R; van Krieken JH; Fitzgerald RC J Med Genet; 2015 Jun; 52(6):361-74. PubMed ID: 25979631 [TBL] [Abstract][Full Text] [Related]
9. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788 [TBL] [Abstract][Full Text] [Related]
10. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome. Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355 [TBL] [Abstract][Full Text] [Related]
11. Family's History Based on the Caggiari L; Fornasarig M; De Zorzi M; Cannizzaro R; Steffan A; De Re V Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664545 [TBL] [Abstract][Full Text] [Related]
12. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer. Pena-Couso L; Perea J; Melo S; Mercadillo F; Figueiredo J; Sanches JM; Sánchez-Ruiz A; Robles L; Seruca R; Urioste M Eur J Hum Genet; 2018 Sep; 26(9):1348-1353. PubMed ID: 29769627 [TBL] [Abstract][Full Text] [Related]
13. CDH1 germline mutations in families with hereditary lobular breast cancer. Girardi A; Magnoni F; Vicini E; Kouloura A; La Vecchia C; Veronesi P; Corso G Eur J Cancer Prev; 2022 May; 31(3):274-278. PubMed ID: 33990097 [TBL] [Abstract][Full Text] [Related]
14. Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant. Yelskaya Z; Arnold AG; Marcell VJ; Tang LH; Salo-Mullen EE; Strong VE; Stadler ZK; Zhang L Eur J Hum Genet; 2021 Jul; 29(7):1103-1109. PubMed ID: 33619332 [TBL] [Abstract][Full Text] [Related]
15. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Pinheiro H; Oliveira C; Seruca R; Carneiro F Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729 [TBL] [Abstract][Full Text] [Related]
17. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021 [TBL] [Abstract][Full Text] [Related]
20. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. Ghaffari SR; Rafati M; Sabokbar T; Dastan J Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]